EssilorLuxottica Shares Plunge 30% in Three Months, Hitting a Critical Threshold
EssilorLuxottica's stock continues its decline this Friday, March 6, falling nearly 2% by midday to settle at 211.70 euros. This session's downturn is part of a pronounced downward trend, with the stock having lost more than 11% over the past seven days and 30% over three months. The Franco-Italian optical group is undergoing a severe correction, bringing its valuation to levels not seen in a long time.
Significant Divergence from Moving Averages and Extreme Selling Pressure
EssilorLuxottica's stock price is now significantly below its reference moving averages: the 50-day moving average at 255.97 euros, and the 200-day moving average at 267.75 euros, which are respectively 20% and 26% above the current level. This considerable gap reflects the magnitude of the correction underway in recent weeks. The Relative Strength Index (RSI) has reached a level of 21, indicating a particularly marked oversold threshold. This indicator, which oscillates between 0 and 100, signals an oversold zone when it drops below 30: at 21, it reveals intense and unusual selling pressure on the stock. Moreover, the price has touched the lower Bollinger band (210.27 euros), confirming the extreme tension the stock is under. The technical support identified at 214.40 euros was breached during the session, paving the way for a potential continuation of the decline in the absence of a positive catalyst.
Recent Stock Trajectory Heavily Impacts Annual Performance
The recent trajectory of the stock has heavily impacted the group's annual performance, now showing a decline of 24.45% over the year. This correction comes as the global leader in optics and corrective lenses has not communicated any new information that could alter the perception of its fundamentals for several weeks. The next major market event is scheduled for April 22, 2026, when the first quarter revenue figures will be published. This date will be closely monitored as it will be the first milestone of the year to assess the group's business dynamics in an uncertain macroeconomic context. The annual general meeting, scheduled for April 28, will be another moment of focus for shareholders seeking clarity on strategy and outlook. Until then, the absence of financial publications leaves the stock without a fundamental anchor that could curb the ongoing movement.
